POSC350 Health Utility Values in the STEP 1–4 Trials of Semaglutide 2.4 MG in Obesity
Autor: | Meincke, H, Bjorner, JB, Holst-Hansen, T, Grand, TS |
---|---|
Zdroj: | In Value in Health January 2022 25(1) Supplement:S240-S240 |
Databáze: | ScienceDirect |
Externí odkaz: |